Mydecine Innovations Group Inc C.MYCO

Alternate Symbol(s): MYCOF

Healthcare Advertising Agencies

Mydecine Innovations Group Inc. is a Canada-based biotechnology company. The Company is engaged in developing medications and therapies to address mental health disorders, such as nicotine addiction and posttraumatic stress disorder (PTSD). The Company conducts research and development on second generation compounds in Canada with a focus on developing and commercializing psychedelic-inspired regulated medicines. The Company has two lead 3,4-Methylenedioxymethamphetamine (MDMA) candidates. The Company is channeling its MYCO-005, MYCO-006, and MYCO-007 families of patent-pending second-generation MDMA and Psilocybin analogs through Applied Pharmaceutical Innovation (API). It utilizes artificial intelligence (AI) and pharma research infrastructure at the University of Alberta to develop and manufacture new medications to make them accessible to the general public upon Health Canada and Food and Drug Administration (FDA) approval.

CSE:MYCO - Post by User

Mydecine Innovations Group Inc

Bullboard Posts

Comment by MJgroweron Jan 18, 2017 3:19pm

32 Views

Post# 25724424

RE:Anon dump might be Carmen again

Good so does than mean you won't post anymore...sadly I think you will...OMG were you the anon selling all those shares?

AngeIs333 wrote:
Thoghts Kathy said everyone here was novice unsuspecting and dumb.That post that was not supposed to be posted here confirms she thinks we are all dirt..I sold everything just now OUT

Bullboard Posts

BMO evolves InvestorLine with enhanced tools for options trading